Results 201 to 210 of about 793,066 (378)

The pressor compounds of the pituitary gland [PDF]

, 1914
A. C. Crawford, Z. Ostenberg
openalex   +1 more source

Clinical Advances and Challenges in Dose Constraints for Organs at Risk in Proton Therapy: A Systematic Review of the Last Decade's Literature

Precision Radiation Oncology, EarlyView.
This systematic review synthesizes decade‐long evidence from peer‐reviewed literature and clinical guidelines, critically evaluating current understanding of OARs tolerance in proton therapy. Abstract Proton beam therapy has demonstrated significant clinical efficacy across multiple malignancies, primarily attributed to its distinct physical dose ...
Jinghao Duan, Cheng Tao, Shizhang Wu, Chengqiang Li, Jinhu Chen, Tianyuan Dai, Yunyi Fan, Tong Bai, Xiangjuan Meng, Tian Kong, Jian Zhu   +10 more
wiley   +1 more source

A Medical Rarity: Isolated <i>Toxoplasma gondii</i> Abscess in the Pituitary Gland of an Immunocompetent Patient. [PDF]

Case Rep Infect Dis
Taule EM, Miletic H, Mahesparan R.
europepmc   +1 more source

THE DIFFERENTIAL MIGRATION OF THE PRESSOR AND OXYTOCIC HORMONES IN ELECTROPHORETIC STUDIES OF THE UNTREATED PRESS-JUICE OF THE POSTERIOR LOBE OF THE PITUITARY GLAND

, 1938
George W. Irving, Vincent du Vigneaud
openalex   +1 more source

Predicting Residual 21‐Hydroxylase Enzymatic Activity in Pediatric and Adult Congenital Adrenal Hyperplasia Patients: Towards Individualized Therapy

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Congenital adrenal hyperplasia (CAH) is a genetic disorder characterized by impaired cortisol production and consequent elevated adrenocorticotropic hormone (ACTH): CAH patients often require lifelong hydrocortisone therapy. Disease severity reflects residual 21‐hydroxylase enzyme activity, crucial for cortisol synthesis.
Davide Bindellini, Robin Michelet, Yersultan Mirasbekov, Qizong Lao, Charles Sukin, Wilhelm Huisinga, Deborah P. Merke, Charlotte Kloft   +7 more
wiley   +1 more source

NOVA2 expression in pituitary gland and in functioning and non-functioning pituitary adenomas: a preliminary study. [PDF]

Acta Neurochir (Wien)
De Bonis P, Ghidoni F, Tisato V, Rimondi E, Gafà R, Picciocchi M, Zatelli MC, Scerrati A, Cavallo MA, Madoglio A.   +9 more
europepmc   +1 more source

Experiment K-6-22. Growth hormone regulation, synthesis and secretion in microgravity. Part 1: Somatotroph physiology. Part 2: Immunohistochemical analysis of hypothalamic hormones. Part 3: Plasma analysis [PDF]

The objectives of the 1887 mission were: (1) to determine if the results of the SL-3 pituitary gland experiment (1) were repeatable; and (2) to determine what effect a longer mission would have on the rat pituitary gland growth hormone (GH) system.
Grindeland, R., Hymer, W., Kaplanski, A., Krasnov, I., Sawchenko, P., Vale, W., Vasques, M., Victorov, I.   +7 more
core   +1 more source

THE RÔLE OF THE PITUITARY GLAND IN EPILEPSY [PDF]

, 1920
Belinda Tucker
openalex   +1 more source

Clinical perspectives and comparisons between immunoglobulin G4‐related disease and antineutrophil cytoplasmic antibody‐associated vasculitis

Rheumatology &Autoimmunity, EarlyView.
Clinical perspectives and comparisons between immunoglobulin G4‐related disease and antineutrophil cytoplasmic antibody‐associated vasculitis. Abstract Both immunoglobulin (Ig) G4‐related disease (IgG4‐RD) and antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV) are systemic disorders that affect a wide range of organs.
Wenhuan Zeng, Mingxin Bai, Yanying Liu
wiley   +1 more source

Duplicated pituitary gland plus syndrome with thoracoabdominal findings suggesting abnormal axial mesodermal signaling and ciliopathy. [PDF]

Pediatr Radiol
Sarma A, A Knake L, Hernanz-Schulman M, Cassini T, Pruthi S.   +4 more
europepmc   +1 more source